EIX vs EYPT · P/E 7.3, rev $19.32B vs rev $1.2M
Edison International (EIX) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2025-12-31 was $19.32B. Net income was $4.46B. Revenue was up 9.8% from 2024-12-31 to 2025-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the EIX and EYPT stock pages for the full models.
Not investment advice.